(Q36879686)

16 August 2017

1 reference

title

Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review (English)

1 reference

16 August 2017

0 references

W Sterry

1

1 reference

16 August 2017

B E Strober

series ordinal

2

1 reference

16 August 2017

A Menter

series ordinal

3

1 reference

16 August 2017

International Psoriasis Council

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

11 July 2007

1 reference

British Journal of Dermatology

16 August 2017

1 reference

16 August 2017

157

1 reference

16 August 2017

4

1 reference

16 August 2017

649-655

1 reference

Obesity and diabetes in the developing world--a growing challenge

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Obesity as the core of the metabolic syndrome and the management of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Disease concomitance in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

The immunologic basis for the treatment of psoriasis with new biologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Nonalcoholic steatohepatitis associated with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Methotrexate and histologic hepatic abnormalities: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Methotrexate in psoriasis: consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Circulating endothelial progenitor cells and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Psoriasis and occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Lipid profile, insulin secretion, and insulin sensitivity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Psoriasis: a possible risk factor for development of coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Effects of etanercept in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08068.X

10.1111/J.1365-2133.2007.08068.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference